[Federal Register Volume 61, Number 217 (Thursday, November 7, 1996)]
[Notices]
[Pages 57691-57692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Cancer Institute; Notice of Meeting of the National 
Cancer Advisory Board and Its Subcommittees

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the National Cancer Advisory Board, National Cancer 
Institute, and its Subcommittees on November 18-20, 1996. Except as 
noted below, the meetings of the Board and its Subcommittees will be 
open to the public to discuss issues relating to committee business as 
indicated in the notice. Attendance by the public will be limited to 
space available.
    The Committee Management Office, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Room 630E, 9000 
Rockville Pike, Bethesda, Maryland 20892 (301/496-5708), will provide 
summaries of the meetings and rosters of the Board members, upon 
request.
    A portion of the Board meeting will be closed to the public in 
accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Public Law 92-463, for 
the review, discussion and evaluation and discussion of issues 
pertaining to intramural programmatic areas and/or NCI personnel and 
discussion of recommendations regarding NCI staff. These discussions 
could reveal confidential trade secrets or commercial property such as 
patentable material, and personal information concerning the 
individuals associated with the programs, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Ms. Carole Frank, Committee Management Specialist, at 301/496-
5708 in advance of the meeting.

    Name of Committee: Policy and Advocacy Ad Hoc Subcommittee.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600A, 
61030 Executive Blvd., Bethesda, MD 20892-7405; (301) 496-4291.
    Date of Meeting: Nov. 18, 1996.
    Place of Meeting: Conference Room 8, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 7:00 pm to 8:00 pm.
    Agenda: To discuss the role of the NCAB in advocacy activities 
and in advising NCI on extramural and intramural policy.

    Name of Committee: Subcommittee on Clinical Investigations.
    Contact Person: Dr. Robert E. Wittes, Acting Executive 
Secretary, National Cancer Institute, NIH, Building 31, Room 3A52, 
9000 Rockville Pike, Bethesda, MD 20892; (301) 496-4291.
    Date of Meeting: November 18, 1996.
    Place of Meeting: Conference Room 8, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: 8:15 pm to 9:30 pm.
    Agenda: To discuss clinical trials reimbursement issues.

    Name of Committee: National Cancer Advisory Board.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Plaza North, Room 600A, 
6130 Executive Blvd., Bethesda, MD 20892-7405; (301) 496-5147.

[[Page 57692]]

    Dates of Meeting: November 19-20, 1996.
    Place of Meeting: Conference Room 10, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
    Open: November 19--8:30 am to approximately 4 pm; November 20--
8:30 am to approximately 1 pm.
    Agenda: The NCI Director's Report; Legislative Update; Report of 
the President's Cancer Panel; Outcome of the NCAB Retreat and 
Chances in Subcommittee Structure; NCI Planning Principles and NCI 
Planning Retreat Outcomes; FY 99 Bypass Planning Procedures; New 
Business; Intercultural Cancer Council C-Chair Remarks; Program 
Review Group Reports; Report by the Office of Advisory Activities; 
Bishop-Calabresi Report Update; Cancer Genome Anatomy Project; Board 
of Scientific Counselors and Board of Scientific Advisors Activities 
and their interface with this Board; Subcommittee/Ad Hoc 
Subcommittee reports; and Integration of Biotechnology Development 
into NCI Programs.
    Closed: November 19--4:00 pm to approximately 5 pm.
    Agenda: For review and discussion of intramural programs and 
personnel.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to proceed with the meeting as 
scheduled in order to address these issues in a timely manner.

    Catalog of Federal Domestic Assistance Program Numbers: (93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 30, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-28632 Filed 11-6-96; 8:45 am]
BILLING CODE 4140-01-M